Clinical Trial Update: The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice

View source ↗

Summary

Completed clinical trial evaluating the use of Picato (ingenol mebutate) for actinic keratosis in standard clinical practice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Picato (ingenol mebutate)

Snippet

Sponsor: LEO Pharma | Conditions: Actinic Keratosis | Status: COMPLETED